相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening
Steven Forsythe et al.
ANNALS OF BIOMEDICAL ENGINEERING (2020)
Pleural Effusion Aspirate for Use in 3D Lung Cancer Modeling and Chemotherapy Screening
Andrea Mazzocchi et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)
Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study
Konstantinos I. Votanopoulos et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
A multi-site metastasis-on-a-chip microphysiological system for assessing metastatic preference of cancer cells
Julio Aleman et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Glioblastoma's Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research
Seamus Caragher et al.
CANCERS (2019)
Projection-Based 3D Printing of Cell Patterning Scaffolds with Multiscale Channels
Dai Xue et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages
Sathishkumar Baskaran et al.
NEURO-ONCOLOGY (2018)
In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening
Andrea R. Mazzocchi et al.
SCIENTIFIC REPORTS (2018)
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
Helen H. N. Yang et al.
CELL STEM CELL (2018)
Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids
Venktesh S. Shirure et al.
LAB ON A CHIP (2018)
Bioengineered Submucosal Organoids for In Vitro Modeling of Colorectal Cancer
Mahesh Devarasetty et al.
TISSUE ENGINEERING PART A (2017)
Exploration of Dynamic Elastic Modulus Changes on Glioblastoma Cell Populations with Aberrant EGFR Expression as a Potential Therapeutic Intervention Using a Tunable Hyaluronic Acid Hydrogel Platform
Hemamylammal Sivakumar et al.
GELS (2017)
Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy
Mahesh Devarasetty et al.
BIOFABRICATION (2017)
Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A
Masato Chiba et al.
BMC CANCER (2017)
Glioma: experimental models and reality
Krissie Lenting et al.
ACTA NEUROPATHOLOGICA (2017)
A Reductionist Metastasis-on-a-Chip Platform for In Vitro Tumor Progression Modeling and Drug Screening
Aleksander Skardal et al.
BIOTECHNOLOGY AND BIOENGINEERING (2016)
Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces
Mark C. Lloyd et al.
CANCER RESEARCH (2016)
Clonal evolution of glioblastoma under therapy
Jiguang Wang et al.
NATURE GENETICS (2016)
Glioblastoma vaccine therapy disappointment in Phase III trial
Hemi Malkki
Nature Reviews Neurology (2016)
Addressing intra-tumoral heterogeneity and therapy resistance
Brad Rybinski et al.
ONCOTARGET (2016)
A hydrogel bioink toolkit for mimicking native tissue biochemical and mechanical properties in bioprinted tissue constructs
Aleksander Skardal et al.
ACTA BIOMATERIALIA (2015)
A comparison of hyperelastic constitutive models applicable to brain and fat tissues
L. Angela Mihai et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2015)
The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
Yuan Xie et al.
EBIOMEDICINE (2015)
Molecular Characterizations of Glioblastoma, Targeted Therapy, and Clinical Results to Date
Jayson I. L. Bastien et al.
CANCER (2015)
Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro
Aleksander Skardal et al.
ANNALS OF BIOMEDICAL ENGINEERING (2015)
Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384
Yanni Zhu et al.
CANCER BIOLOGY & THERAPY (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme
Adam M. Swartz et al.
IMMUNOTHERAPY (2014)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
Deep sequencing of multiple regions of glial tumors reveals spatial heterogeneity for mutations in clinically relevant genes
Akash Kumar et al.
GENOME BIOLOGY (2014)
Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ
Alexander Schulte et al.
NEURO-ONCOLOGY (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth
Guillem Ramis et al.
PLOS ONE (2012)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Photocrosslinkable Hyaluronan-Gelatin Hydrogels for Two-Step Bioprinting
Aleksander Skardal et al.
TISSUE ENGINEERING PART A (2010)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
